25 results for “Therapeutic Neuroscience”. Showing 25 of 39,449.
Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke.
Neuroscience & Therapeutics published by John Wiley & Sons Ltd. DOI: 10.1111/cns.70345
Parallel CRISPR-Cas9 screens identify mechanisms of PLIN2 and lipid droplet regulation.
Therapeutics, Cajal Neuroscience and Alector; and is a consultant to Modulo
Profiling Tight Junction Protein Expression in Brain Vascular Malformations.
Neuroscience and Experimental Therapeutics, Institute for Biomedical Research of Barcelona
Fujian tablet regulates the Foxo3a/GPX4 axis to promote remyelination and improve motor function in ischemic stroke.
therapeutic principles with contemporary molecular neuroscience, this investigation aims to provide
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders.
Neurosci Rep. 2022 Dec 12;14:28-37. doi: 10.1016/j.ibneur.2022.12.002. eCollection 2023 Jun. The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well
Bridging the translational gap in systems neuroscience: from circuit mechanisms to clinical therapeutics
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.
Neurosci. 2022 Jun 28;14:914017. doi: 10.3389/fnagi.2022.914017. eCollection 2022. Identification of Therapeutic
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Neuroscience, Lundbeck, Merck, Meso Scale Discovery, Neurocrine Biosciences, Prevail Therapeutics
Nervous system in hepatocellular carcinoma: Correlation, mechanisms, therapeutic implications, and future perspectives.
therapeutic potential. Additionally, neural-associated biomarkers like NEDD9, CNTN1, and nerve growth factor (NGF) exhibit prognostic significance, supporting their future clinical application. By systematically integrating neuroscience
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine.
therapeutic potential of BDNF heralds a new era in neuroscience
B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity.
Therapeutics (now Amgen Inc., Thousand Oaks, California, USA), Gaithersburg, Maryland, USA. (9)UCSF Weill Institute for Neurosciences
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Therapeutics, University of Melbourne, Parkville, VIC 3010, Australia; Florey Institute of Neuroscience
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Therapeutics, University of Melbourne, Parkville, VIC 3010, Australia; Florey Institute of Neuroscience
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases.
neuroscience, improved our understanding of disease pathogenesis, and advanced the investigation of therapeutic
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models.
Neurosciences, CR-CHUQ, Laval University, Québec City, Quebec, Canada. (3)Corcept Therapeutics
Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: A critical review.
neuroscience, and immunology will lead to innovative treatment strategies. This comprehensive review discusses the therapeutic
The emerging field of non-invasive brain stimulation in Alzheimer's disease.
neuroscience. In the past few years, non-invasive brain stimulation is increasingly emerging as a therapeutic
A spatially-resolved human brain proteome atlas for understanding function and disease
therapeutic targets including the seizure-associated purinergic receptor P2RX7. This resource bridges molecular and systems neuroscience
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
therapeutic strategies. Carnero Contentti E(1), Correale J(2). Author information: (1)Neuroimmunology Unit, Department of Neuroscience
Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention.
therapeutic options. Current treatments are primarily symptomatic and fail to modify disease progression, emphasizing the urgent need for novel, mechanism-based interventions. Recent advances in molecular neuroscience
Mechanistic insights and emerging therapeutic stratagems for Alzheimer's disease.
neuroscience tools, new inter-relations that aggravate AD are being discovered including pre-existing diseases and exposure to other pathogens. Simultaneously, new therapeutic
Clearance mechanisms of the glymphatic/lymphatic system in the brain: new therapeutic perspectives for cognitive impairment.
The glymphatic/lymphatic system of the brain has been an important
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
therapeutic strategies. Raulin AC(#)(1), Doss SV(#)(1), Trottier ZA(1), Ikezu TC(1), Bu G(2), Liu CC(3). Author information: (1)Department of Neuroscience
Common data elements for clinical research in Friedreich's ataxia.
neuroscience clinical research. The Common Data Element Team developed general common data elements, which are commonly collected in clinical studies regardless of therapeutic
Hypocretins (orexins): The ultimate translational neuropeptides.
therapeutic applications under investigation include reduction of cravings in substance-use disorders and prevention of neurodegenerative disorders such as Alzheimer's disease, given the apparent bidirectional relationship between poor sleep